Curis, Inc. (CRIS)
1.35
-0.02
(-1.46%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
+0.01
(+0.74%)
After-Hours: 20:00
Curis Price to Book Value : 0.5604 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 0.5604 |
| September 03, 2026 | 0.5687 |
| September 02, 2026 | 0.5729 |
| September 01, 2026 | 0.5895 |
| August 31, 2026 | 0.6185 |
| August 28, 2026 | 0.6185 |
| August 27, 2026 | 0.6227 |
| August 26, 2026 | 0.6393 |
| August 25, 2026 | 0.66 |
| August 24, 2026 | 0.6559 |
| August 21, 2026 | 0.6559 |
| August 20, 2026 | 0.6683 |
| August 19, 2026 | 0.714 |
| August 18, 2026 | 0.7057 |
| August 17, 2026 | 0.7472 |
| August 14, 2026 | 0.7472 |
| August 13, 2026 | 0.7763 |
| August 12, 2026 | 0.6933 |
| August 11, 2026 | 0.9589 |
| August 10, 2026 | 1.519 |
| August 07, 2026 | 1.669 |
| August 06, 2026 | 1.831 |
| August 05, 2026 | 1.887 |
| August 04, 2026 | 1.959 |
| August 03, 2026 | 2.138 |
| Date | Value |
|---|---|
| July 31, 2026 | 2.084 |
| July 30, 2026 | 2.059 |
| July 29, 2026 | 2.067 |
| July 28, 2026 | 2.005 |
| July 27, 2026 | 1.947 |
| July 24, 2026 | 2.030 |
| July 23, 2026 | 1.939 |
| July 22, 2026 | 2.051 |
| July 21, 2026 | 1.972 |
| July 20, 2026 | 1.876 |
| July 17, 2026 | 1.922 |
| July 16, 2026 | 2.067 |
| July 15, 2026 | 1.964 |
| July 14, 2026 | 1.930 |
| July 13, 2026 | 1.972 |
| July 10, 2026 | 2.059 |
| July 09, 2026 | 2.059 |
| July 08, 2026 | 2.049 |
| July 07, 2026 | 2.196 |
| July 06, 2026 | 2.466 |
| July 02, 2026 | 2.878 |
| July 01, 2026 | 3.504 |
| June 30, 2026 | 4.335 |
| June 29, 2026 | 1.391 |
| June 26, 2026 | 1.010 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.22 |
| Anika Therapeutics, Inc. | 2.029 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.760 |
Price to Book Value Related Metrics
| PS Ratio | 0.3658 |
| Price | 1.35 |
| Earnings Yield | -1.06K% |
| Market Cap | 2.631M |